Skip to main content

Table 3 Outcomes

From: Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study

 

Duration of MV*

Transferred ventilated***

ICU outcome

Hospital outcome

Days outcome evaluation

Case 1

13

No

Ward

Alive

55

Control 1–1

11

Yes

Dead

Dead

65

Control 1–2

36

Yes

ICU

Alive

52

Case 2

22

Yes

Dead

Dead

55

Control 2–1

19

No

Ward

Alive

44

Control 2–2

20

Yes

Dead

Dead

42

Case 3

27

No

ICU

Alive

49

Control 3–1

24

No

Ward

Alive

50

Control 3–2

21

Yes

Ward

Alive

47

Case 4

7

No

ICU

Alive

45

Control 4–1

16

Yes

Dead

Dead

71

Control 4–2

10

No

Ward

Alive

57

Case 5

16

No

Ward

Alive

37

Control 5–1

16

Yes

Ward

Dead

74

Control 5–2

16

Yes

Ward

Dead

41

Case 6

25

No

ICU

Alive

34

Control 6–1

28

No

ICU

Alive

51

Control 6–2

12

No

Ward

Alive

50

Case 7

10

No

Ward

Alive

32

Control 7–1

6

Yes

Dead

Dead

71

Control 7–2

9

Yes

Dead

Dead

48

  1. *Duration of mechanical ventilation (MV), **ICU-Los = total days in ICU, ***Yes = patients transferred ventilated or dead in ICU
  2. Alive still In ICU, patients alive still in hospital